EASOobesity

EASOobesity EASO represents 36 European nations dedicated to understanding and addressing obesity.

New research to be presented at   in Istanbul:  Using new obesity management medication  in prevention of obesity-relate...
26/03/2026

New research to be presented at in Istanbul: Using new obesity management medication in prevention of obesity-related cancers – global panel of experts propose 10-year trial with 5,000 participants with cancer pre-cursor condition to establish efficacy

https://medicalxpress.com/news/2026-03-experts-year-trial-glp-drugs.html

In new research to be presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May), a global panel of 21 obesity and cancer experts suggest that to test the potential efficacy of the new generation of obesity drugs such as semaglutide and tirzepatide in preventing obesit...

Save the date for the EASO COMs Summit, held in collaboration with the German Obesity Society (DAG), alongside the DAG O...
25/03/2026

Save the date for the EASO COMs Summit, held in collaboration with the German Obesity Society (DAG), alongside the DAG Obesity Congress 2026.

🗓️ 23-25 September 2026
📍Potsdam, Germany

The Summit aims to:
✔️ Share research, emerging evidence, and evolving practice across the COMs network
✔️ Identify opportunities to strengthen obesity management research and service delivery
✔️ Strengthen collaboration between accredited centres
✔️ Support capacity building within multidisciplinary obesity care teams
✔️ Enhance professional networking and structured knowledge exchange
✔️ Improve outcomes and care experiences for people living with obesity

Learn more: https://easo.org/save-the-date-easo-coms-summit-2026/

▶️ The ECPO World Obesity Day Europe Awards  Closing date for entries: 5th May 2026  The ECPO Awards support the develop...
21/03/2026

▶️ The ECPO World Obesity Day Europe Awards

Closing date for entries: 5th May 2026

The ECPO Awards support the development of a stronger and more successful obesity community throughout Europe. In creating a high-profile, wide-reaching and very well-respected awards programme, the European patient community strives to create a stronger community

✔️Drawing attention to European best practices
✔️Sharing learning and experiences ✔️Stimulating debate

Learn more: https://woday.eu/wod-europe-awards/awards/

European Association for the Study of Obesity (EASO) and Novo Nordisk Foundation congratulate the Obesity Prize for Exce...
20/03/2026

European Association for the Study of Obesity (EASO) and Novo Nordisk Foundation congratulate the Obesity Prize for Excellence Award Winner - Professor Sadaf Farooqi from the United Kingdom

👏Obesity Prize for Excellence

⭐ Professor Sadaf Farooqi has been awarded this prestigious prize for her pioneering research over the past two decades, which has fundamentally advanced our understanding of the genetic and biological mechanisms that contribute to the development of obesity. We are pleased to continue our partnership with the Novo Nordisk Foundation in supporting research that advances the science of obesity.

With decades of experience in obesity science and medicine, Professor Farooqi has made an exceptional contribution to the field, authoring 160+ original articles and several reviews. Her research has demonstrated proof-of-principle that leptin is an essential regulator of human energy homeostasis.

👏New Investigator Award Winners

In addition to the Obesity Prize for Excellence, EASO and the Novo Nordisk Foundation have announced four New Investigator awards, each including a research grant of DKK 300,000.

⭐ Basic Science - Jens Lund
⭐ Childhood Obesity - Sara Stinson
⭐ Clinical Research - Nele Steenackers
⭐ Public Health - Edi Putra

Learn more about the awards here:
https://easo.org

EASO was delighted to speak with co-author Dr Emilia Huvinen about the recently published EASO position statement on wom...
19/03/2026

EASO was delighted to speak with co-author Dr Emilia Huvinen about the recently published EASO position statement on women with obesity across the reproductive life course. In our interview, we address these questions:

✔️ Why was it important for EASO to develop a position statement specifically focused on women living with obesity across the reproductive life course, rather than addressing this within broader obesity guidance?

✔️ The statement recommends moving beyond BMI to improve assessment and care, using the parameters outlined in the EASO Framework for Obesity Management. How could this shift change clinical conversations and decision-making for women?

✔️ Psychological support and person-centered care are central themes in the position statement. What does meaningful, respectful care look like in practice for women at different reproductive stages?

✔️ Evidence suggests relatively modest weight reduction can improve fertility outcomes. How can clinicians discuss this in a way that supports and empowers women without reinforcing stigma or creating unrealistic expectations?

Read Emilia’s responses and review this important Position Statement: https://easo.org/easo-position-statement-on-women-with-obesity-across-the-reproductive-life/

Address


Alerts

Be the first to know and let us send you an email when EASOobesity posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to EASOobesity:

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

COVID-19 AND OBESITY

The EASO medical and scientific community all across Europe is intensively engaged in addressing the global COVID-19 pandemic. Our clinicians are working in the front line of care daily for patients living with obesity within emergency care systems, in coordination with other clinical colleagues across 34 countries. Our scientists are hard at work developing tools and frameworks for contributing to psychological support for clinicians and patients, developing and implementing public health strategies, providing guidance and support for whole family assistance, and development and provision of advice for children and teens.

Our role in this crisis will be crucial in the dissemination of science-based information and providing common-sense, evidence-based updates, recommendations and guidance via our website and social media, that can reach millions of people. EASO is committed to sharing only the latest well evidenced information and guidance from credible sources.

People living with the chronic disease obesity are particularly vulnerable to the effects of the novel coronavirus, and appear to have a higher rate of serious complications from the virus. It is paramount that people with obesity avoid infection. We herein recommend that people with obesity shelter at home during this time, following their national guidance for vulnerable people living with chronic disease.

Infographics developed in conjunction with our scientific and patient communities focused on energy balance; mental health; family life with children and adolescents;and indoor exercise, all helpful during COVID-19, are available for download on the EASO website.